InjuryBoard Denver Archives

  • Ortho Evra Suit Filed

    Staff Writer | June 30, 2006 7:15 PM | 0 Comments
    Category: FDA & Prescription Drugs

    On June 30, a new suit was filed against Ortho McNeil Pharmaceutical, Inc., a division of Johnson & Johnson (NYSE:JNJ), on behalf of a 46-year-old woman and her husband. The woman suffered a stroke while using the Ortho Evra(r) Birth Control Patch for only three months. The suit was filed in The Superior Court of New Jersey near Johnson and Johnson's world headquarters.

  • FDA Toughens Warnings of Liver Failure on Ketek

    Staff Writer | June 30, 2006 6:20 PM | 0 Comments
    Category: FDA & Prescription Drugs

    In its second Safety Information Alert in six months, the FDA announced it is mandating tougher warnings about liver toxicity and liver failure, after receiving reports of four deaths and one liver transplant, in patients who were taking the antibiotic Ketek. Ketek was approved in April, 2004, for upper respiratory infections in adults. The drug's maker, Aventis-Sanofi SA, had been testing the...

  • How Independent is Medical Research?

    Staff Writer | June 30, 2006 9:13 AM | 0 Comments
    Category: FDA & Prescription Drugs

    In a recent New York Times story, it was reported that drug companies are pouring large sums of money into medical research through non-profit groups directed by the doctors who are doing the research. In addition, the doctors actually doing the research are often paid consultants to the drug companies themselves. As a result, the risk that drug companies are influencing the direction and...

  • Retaliation Claims Under Title VII

    Staff Writer | June 29, 2006 4:45 PM | 0 Comments
    Category: Workplace Discrimination

    On June 22, 2006, the United States Supreme Court rendered entered a new, sweeping decision concerning retaliation claims under Title VII, which gives victims of retaliation greater protection than victims of actual discrimination. In Burlington Northern & Santa Fe Railroad v. White, an opinion authored by Justice Breyer, the Supreme Court decided for the first time that an employer may be...

  • FDA Plans Web-Based Reporting for Adverse Events

    Staff Writer | June 29, 2006 9:38 AM | 0 Comments
    Category: FDA & Prescription Drugs

    The FDA announced last week that it is developing a single elecronic web-based system for reporting information about drug safety problems. The FDA hopes to have the new system in place within two years, though no firm timetable has been established. "The system will be easy to use, so that the general public is encouraged to report incidents and is not deterred by the nature of the...

  • Three Months of Vioxx Use Can Damage Heart

    Staff Writer | June 28, 2006 9:25 AM | 0 Comments
    Category: FDA & Prescription Drugs

    The New England Journal of Medicine published a correction June 26, 2006, saying that it does not take 18 months of Vioxx use to increase heart risk, but that heart risks could occur after as few as three months of use. The correction is expected to undermine Merck & Co.'s ability to defend itself against thousands of lawsuits.Dr. Gregory D. Curfman , executive editor of the New England...

  • Pharmacy Workload Increasing

    Staff Writer | June 23, 2006 6:03 PM | 0 Comments
    Category: Miscellaneous

    Recent data reports that the average pharmacist's work load increased a staggering 35% between 1992 and 2000. This increase is a statement of the number of prescriptions dispensed per pharmacist per year. With a significant increase in work load, the question is how pharmacists have time to either accurately fill [or double-check the filling of] prescriptions. Further, as work load increases...

  • Fanconi Anemia Chemo Cap Project

    Staff Writer | June 22, 2006 6:32 PM | 0 Comments
    Category: Miscellaneous

    Kendall Atkinson died from Fanconi Anemia, a disease that led to bone marrow failure, on March 14, 2004 at the age of 20. In memory of their sister, Allison and Whitney launched "Kaps for Kendall." The goal is to raise money to fight the disease that took the life of their sister and to provide special hats for kids and adults who have lost their hair from chemotherapy and radiation. Many...

  • Controversy over expert testimony back in the public eye

    Staff Writer | June 22, 2006 4:07 PM | 0 Comments
    Category: Miscellaneous

    The USA Today cover story on June 21, 2006, adds to the chorus of controversy over the use of expert testimony, particularly mental health experts (psychologists, psychiatrists, therapists, etc), at trials. This article uses the Andrea Yates murder conviction (the woman who drowned her five children in the family bathtub), and the subsequent determination by the Texas Court of Appeals that her...

  • Noneconomic and Punitive damages: Ortho Evra

    Staff Writer | June 22, 2006 8:57 AM | 0 Comments
    Category: FDA & Prescription Drugs

    Federal Judge David Katz of Toledo has asked Ohio's highest court to decide whether Ohio's cap on in civil lawsuits is constitutional. Judge Katz made this request because it could affect a lawsuit before him in which Ohio litigants are suing Ortho Evra, alleging the company's birth control patch caused serious side effects or death. The caps on damages awards have been passed by the state...

  • Suit filed against Bausch and Lomb-Fusarium Keratitis

    Staff Writer | June 21, 2006 6:16 PM | 0 Comments
    Category: FDA & Prescription Drugs

    In a recent personal injury and product liability lawsuit filed in Federal court in St. Louis, Renu with MoistureLoc is being blamed for an eye infection (Fusarium Keratitis) and a subsequent cornea transplant. The suit alleges that Bausch and Lomb was negligent and failed to warn customers that the solution could cause serious and permanent injury. There have been 125 other similar cases...

  • New Studies: COX-2 Inhibitors and NSAIDs

    Staff Writer | June 21, 2006 3:59 PM | 0 Comments
    Category: FDA & Prescription Drugs

    Publication of a new study in medicine is nothing new. But one of the recent studies published in a medical journal which is being publicized in the popular press highlights that it is important not only for pharmacists and doctors to stay on top of new research in medicine, but it is critical for patients to take care to inform doctors and pharmacists of medicines they may be taking. The new...

  • Recall of all Triaminic Vapor Patch

    Staff Writer | June 20, 2006 3:56 PM | 0 Comments
    Category: FDA & Prescription Drugs

    Novartis Consumer Health and FDA notified patients, pharmacists and other healthcare professionals that the sponsor is conducting a nationwide voluntary recall of all Triaminic Vapor Patch products due to reports of serious adverse events associated with accidental ingestion by children. Triaminic Vapor Patch is labeled as a cough suppressant for children two (2) years of age and older and is...

  • New Urbanism Projects and Reordered Risks of Trend

    Staff Writer | June 20, 2006 1:15 PM | 0 Comments
    Category: Workplace Injuries

    New Urbanism is, with the new world of lifestyle choices and development opportunities, among the most prominent current concepts in city planning and development. Typically this type of real estate development is the creation of diverse, walkable and compact communities with mixed-use elements including high-rise condominiums.Along with these development opportunities developers are also...

  • Triaminic Cough-Suppressing Vapor Patches Recalled After Child Suffers Seizure

    Staff Writer | June 19, 2006 4:05 PM | 0 Comments
    Category: FDA & Prescription Drugs

    Novartis AG has recalled its Triaminic cough-suppressing vapor patches and warns consumers to stop using them immediately. The warning applies to both the mentholated cherry and menthol scented versions. A child suffered a seizure after chewing on one of the patches. Novartis said the patches are to be placed on the chest or throat of children as young as 2 to allow vapors to reach the nose...

  • Renu MoistureLoc and Fusarium Keratitis

    Staff Writer | June 19, 2006 11:00 AM | 0 Comments
    Category: FDA & Prescription Drugs

    In early 2006, a cluster of four cases of fusarium keratitis was seen at the University of California, San Francisco. Each of the four patients used ReNu with MoistureLoc. In fact, three of the four had been young, otherwise healthy women who used ReNu with MoistureLoc exclusively. Ironically, it was a cluster of four cases of fusarium keratitis in ReNu with MoistureLoc users in February 2006...

  • Lawsuit Claims Sunscreens Don't Protect as Claimed

    Staff Writer | June 19, 2006 9:22 AM | 0 Comments
    Category: FDA & Prescription Drugs

    In a recent article on CNN.com, attorneys have filed a lawsuit in California Superior Court, alleging that the claims made by labels on sunscreen products are misleading, and not offering all the protection they claim. The lawsuit focuses on some of the products sold by Coppertone, Hawaiian Tropic, Banana Boat, Bull Frog, and Neutrogena, because those products make claims such as "UVB/UVA...

  • Adverse Event Report on Defibrillators

    Staff Writer | June 16, 2006 3:51 PM | 0 Comments
    Category: Medical Malpractice

    MRL, Inc. and FDA notified healthcare professionals of a voluntary worldwide Class I recall of 580 AED20 automatic external defibrillators because of an intermittent electrical connection that could result in failure, delay in analyzing the patient's ECG or failure to deliver expected therapy and resuscitation of the patient. A Class 1 recall occurs when there is reasonable probability that use...

  • Commercial Construction and Builder Contracts

    Staff Writer | June 15, 2006 7:19 PM | 0 Comments
    Category: Miscellaneous

    A friend of mine recently posed the following question to me in regard to commercial construction and the corresponding contract that he entered into with his builder: My company contracted with a builder to construct a new commercial office building for my business. After we moved in, we had numerous problems that I believe the builder is responsible for. The builder told me that we have a...

  • Bextra/Celebrex Multi District Litigation

    Staff Writer | June 15, 2006 9:31 AM | 0 Comments
    Category: FDA & Prescription Drugs

    In the Bextra/Celebrex MDL, Judge Breyer is holding a hearing today in San Francisco on Pfizer's motion to dismiss the claims of consumers, labor unions and insurance companies that allege they wrongfully paid for these drugs as a result of Pfizer's improper conduct. A ruling, however, will not be expected for several weeks.

  • Johnson and Johnson Will Retest Heart Medication Natrecor

    Staff Writer | June 14, 2006 8:10 PM | 0 Comments
    Category: FDA & Prescription Drugs

    Johnson and Johnson announced that its Scios unit will spend over $100 million to test the safety and effectiveness of its heart failure drug, Natrecor. The new study will involve 7,000 people and will test safety issues that arose last year when other studies showed that the drug could lead to an increased risk of kidney problems and a higher risk of mortality within the first month of...

  • Asthma Drugs Found to Increase Risk of Hospitalization and Death . . . From Asthma!

    Staff Writer | June 14, 2006 8:07 PM | 0 Comments
    Category: FDA & Prescription Drugs

    The Washington Post recently reported that a new analysis of 19 studies of long-acting asthma medicines, such as Advair and Servent, shows that the risk of hospitalization and death is substantially increased over those who used placebos. "What we have here is a drug that increases the number of people who will die from the disease it is treating," said lead author Shelley Salpeter of Stanford...

  • FDA Urges Halt of Ketek Antibiotic Trials in Children

    Staff Writer | June 14, 2006 8:04 PM | 0 Comments
    Category: FDA & Prescription Drugs

    An official within the FDA called for a halt of clinical trials in children of Sanofi-Aventis' antibiotic, Ketek, based on concerns that the drug might be deadly. The drug is being tested on ear infections and tonsillitis in nearly 4,000 infants and children in over a dozen countries, including the U.S., in spite of its having caused liver failure, blurred vision, and loss of consciousness in...

  • Zyprexa Litigation

    Staff Writer | June 14, 2006 8:00 PM | 1 Comments
    Category: FDA & Prescription Drugs

    On June 8th, Judge Weinstein (the federal judge overseeing the Zyprexa litigation and $700 million settlement) issued an order that if claimants in the settlement do not have their claims submitted to the Special Masters with the necessary documents to support their claim "conforming to the guidelines agreed upon in the Final Settlement Protocol" by July 17th, their claims will be deemed...

  • Are Arbitration Clauses Enforceable in Colorado?

    Staff Writer | June 14, 2006 7:18 PM | 0 Comments
    Category: Miscellaneous

    Several people have asked me the if arbitration clauses are enforceable in Colorado. They are absolutely enforceable. In fact, Colorado case law strongly favors such clauses. Arbitration clauses are generally considered to be favorable to defendants and businesses, although the better practice is to decide whether to include an arbitration agreement on a case by case basis. The court system...

  • Dying Patients have Right to Experimental Drugs

    Staff Writer | June 05, 2006 1:28 PM | 0 Comments
    Category: FDA & Prescription Drugs

    A federal appeals court has ruled that, just as terminally ill patients have a right to die and refuse treatment, they also have a right to take all measures available to them to sustain their lives. The court's ruling allows dying patients access to experimental drugs that have passed the first phase of FDA review, which determines whether a product is safe, even prior to full FDA approval.The...

  • Pfizer Accused of Unapproved Testing on Children

    Staff Writer | June 04, 2006 1:41 PM | 0 Comments
    Category: FDA & Prescription Drugs

    A panel of Nigerian medical experts issued a report concluding that Pfizer, Inc., illegally tested its unapproved drug, Trovan, on children and infants during a 1996 epidemic of deadly meningitis in Kano, Negeria. Pfizer contends that its use of the unapproved drug was purely for philanthropic reasons, but the Nigerian panel called it a "clear case of exploitation of the ignorant," in its...

  • Boca Medical Ultilet and Closercare Insulin Syringes Recalled

    Staff Writer | June 03, 2006 1:36 PM | 0 Comments
    Category: FDA & Prescription Drugs

    The FDA's Medwatch has issued an alert to consumers and healthcare professionals regarding the expansion of an earlier recall of Ultilet insulin syringes and the additional recall of Closercare insulin syringes because of bacterial contamination with Paenibacillus. This bacteria presents a risk of local infection due to soft tissue injection with a contaminated syringe, and also a risk of...

  • Doggy Vioxx is Risky, too

    Staff Writer | June 02, 2006 1:30 PM | 0 Comments
    Category: FDA & Prescription Drugs

    Most people are aware by now that Vioxx, a prescription anti-inflammatory manufactured by Merck & Co., has been associated with an increased risk of heart attack and stroke. But few people know that Deramaxx, an anti-inflammatory medication for dogs which is closely related to Vioxx, has been associated with hundreds of deaths in dogs. Recently, The Washington Post reported that more than 350...

  • Eye-Infection Cases Have Required Corneal Transplants

    Staff Writer | June 01, 2006 1:22 PM | 0 Comments
    Category: FDA & Prescription Drugs

    Thirty-seven of 120 people who experienced a severe fungal infection from using Bausch & Lomb's RuNu with MoistureLoc contact solution have required corneal transplants, according to an article on health.msn.com. That's 31%, and experts expect that the percentage may climb as high as 50 percent. Bausch & Lomb permanently removed the contact solution, which was used by about 2.3 million...

  • Is it frivolous when it affects you or yours?

    Staff Writer | June 01, 2006 10:34 AM | 0 Comments
    Category: Medical Malpractice

    I read a story today about a Tacoma physician filing a medical malpractice lawsuit involving his wife's recent death. While you cannot make a good determination based on just what you read in the papers, it appears as if her death should have been prevented. We, of course, sympathize with the family and offer our condolences.Medical malpractice damage caps affect us all. I hope our legislators...

Subscribe to InjuryBoard Denver

InjuryBoard Denver RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Denver is brought to you by Bachus & Schanker, LLC

Legal Assistance Center

More Info
Bachus & Schanker, LLC (866) 735-1102 Ext 425 www.coloradolaw.net
google
Personal Injury Lawyers Serving: Denver, Fort Collins, Colorado Spring, Grand Junction, Cheyenne and all surrounding areas. Offices in Denver, Fort Collins and Colorado Springs
1400 16th StreetSuite 450, Denver, Colorado 80202 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.